Published On : 12 Oct 2016
Protein biochips contain protein microarray with an arrangement of various proteins including antibodies. These protein agents capture certain proteins from a sample. Many companies manufacture protein biochips and the many components that are required to make them. Biochips with many DNA fragments are primarily used to examine the genetic material. Experts also use protein-anchored biochips for many purposes. The growing number of companies manufacturing protein biochips is expected to propel the global market in the years to come, finds a new report added by QYResearchReports.com to its expanding database of research reports.
The report, titled “Global Protein Biochips Market Research Report 2016,” highlights key players operating in the global market and the many applications of protein biochips. The report also briefs readers about the many product types of protein biochips and the new product developments. The feasibility of new products is studied in the report by using industry-standard tools such as the SWOT analysis tool.
The report on the global protein biochips market highlights the many challenges faced by key manufacturers. As per the findings of the report, protein biochip systems will have to overcome a few challenges, which are not applicable to DNA chips. While manufacturing protein biochips, the manufacturers have to consider the many human proteins that are available. This is a key challenge for the companies aiming to manufacture new protein biochips. However, key companies are introducing a wide variety of solutions to fight the challenges and manufacture new protein biochips as per the requirements of end-use industries. This is expected to create new growth opportunities in the global protein biochips market, finds the analysts.
To get sample copy of report visit @ https://www.qyresearchreports.com/sample/sample.php?rep_id=816188&type=E
As per the findings of the report, protein biochips find application in versatile use, research, clinical use, fetal cell separation, stem cell sorting, biomedical research, drug discovery, microbiology, and marine biology and environmental science. By region, the global protein biochips market is divided into Europe, North America, and Southeast Asia. Key players across the many regions are concentrating on increasing the use of protein biochips in many new applications, which is one of the key factors expected to propel the global market.
GE Healthcare (UK), Becton, Dickinson and Company (US), 3M Purification, Inc. (US), Merck KGaA (Germany), AB Sciex (US), Alfa Laval AB (Sweden), PerkinElmer, Inc. (US), Affymetrix Inc. (US), Agilent Technologies, Inc. (US), Sartorius Stedim Biotech SA (France), Alfa Wassermann Inc. (US), Atoll GmbH (Germany), Beckman Coulter, Inc. (US), Bio-Rad Laboratories, Inc. (US), and Flottweg SE (Germany) are some of the leading companies operating in the global protein biochips market.
Key companies operating in the global protein biochips market are profiled with information such as protein biochip product types, competitors, application, specifications, and gross margin. The report also highlights other details such as upstream raw materials, downstream buyers, sources of raw materials for manufacturing protein biochips, and various marketing strategies used by key companies. Technological advancements and changes in customer preferences are also listed in the report by the analysts. The impact of changing government policies is also mentioned in the report.